Answers are grounded in this paper and cite their sources.
Induced pluripotent stem cell (iPSC)-derived organoids are three-dimensional in vitro models that recapitulate se-lected structural and functional features of human tissues. They provide useful platforms for studying development and disease, screening drugs, and exploring regenerative medicine. This review examines strategies for generating iPSC-derived organoids across multiple organ systems, with a comparative focus on how differentiation logic and culture design influence organoid development. Specifically, we discuss guided differentiation using developmental signaling cues and unguided approaches that rely on the cells’ intrinsic capacity for self-organization. We also con-sider scaffold-based and scaffold-free culture methods and how these approaches, together with organ-specific proto-cols, affect organoid formation and maturation. In addition, we summarize signaling pathways commonly used to direct differentiation and the biomedical applications of iPSC-derived organoids. Despite their promise, these models may show variability between cell lines, incomplete maturation, and limited oxygen and nutrient delivery to their inner regions, which can contribute to necrotic core formation. Further refinement of differentiation protocols, culture conditions, and characterization standards may improve the reproducibility and physiological relevance of organoids. By comparing differentiation strategies and culture approaches across organ systems, this review provides a framework for understanding how protocol choices shape organoid development and for guiding future studies in disease modeling, drug discovery, and regenerative medicine.
No takes yet. Share an insight, caveat, or question.
Siahmazgi et al. (2026) studied this question.
Synapse has enriched 8 closely related papers on similar clinical questions. Consider them for comparative context: